Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 27 June 2013 | By Alexander Gaffney, RAC,
Australia's Therapeutic Goods Administration (TGA) has become the latest global regulatory agency to look to better define what it considers to be commercially confidential information (CCI), launching a new consultation on 27 June 2013 that explains in extensive detail what such information is-and just as importantly, is not.
The document, Draft TGA Approach to Disclosure of Commercially Confidential Information, may be most notable for the information it says it will not release to the public: clinical data.
In recent months, a bevy of regulators, including those in the EU and US, have taken steps (and in the case of the EU, large ones) toward releasing clinical data to additional experts and the public in general. Australia, however, appears to be re-affirming that such data is considered CCI under established practices.
"Commercially confidential information held by the TGA may include … certain information about clinical trials," TGA writes in the document, including the "outcome of testing of a product or investigations into its performance."
In addition, commercial entities will have avenues to contest the release of any information they believe to be CCI. "Any decision to release information to the public on a regular or systematic basis about any aspect of its regulatory functions that could involve the release of commercially confidential information will be preceded by consultation with affected stakeholders and the release appropriately authorized under legislation," TGA wrote.
The document goes on to list eight "principles" of CCI:
The consultation on the document is open through 29 August 2013.
Draft TGA Approach to Disclosure of Commercially Confidential Information
Consultation Information
Tags: CCI, australia, clinical trials
Regulatory Focus newsletters
All the biggest regulatory news and happenings.